# OnCo record nct07287995 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07287995/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07287995", "NCT07287995" ;
  schema:name "A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors"@en ;
  schema:description "An early study of ASP2998, an experimental antibody drug carrying a cancer-killing payload and an immune activator. It is recruiting people with advanced solid tumors for treatment alone or with tumor-specific standard therapies."@en ;
  schema:url <https://onco.cc/trials/nct07287995/> ;
  schema:dateModified "2026-10-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07287995>, <https://www.clinicaltrials.astellas.com/study/2998-CL-0101>, <https://www.astellas.com/content/dam/astellas-com/global/en/confidential-documents/financial-results/4q2025_pre_en.pdf>, <https://doi.org/10.1200/jco.2026.44.16_suppl.tps2665> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2026-02-05" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/dual-payload-adc/> ;
  onco:targets <https://onco.cc/targets/trop2/> ;
  onco:drugs <https://onco.cc/drugs/asp2998/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/enfortumab-vedotin/>, <https://onco.cc/drugs/carboplatin/> ;
  onco:companies <https://onco.cc/companies/astellas/> .